Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging

被引:8
|
作者
Monkman, James [1 ]
Moradi, Afshin [1 ]
Yunis, Joseph [1 ,2 ]
Ivison, Geoff [3 ]
Mayer, Aaron [3 ]
Ladwa, Rahul [4 ]
O'Byrne, Ken [4 ]
Kulasinghe, Arutha [1 ]
机构
[1] Univ Queensland, Frazer Inst, Fac Med, 37 Kent St, Woolloongabba, Qld 4102, Australia
[2] Univ Queensland, Fac Med, Ian Frazer Ctr Childrens Immunotherapy Res, Childrens Hlth Res Ctr, Brisbane, Qld, Australia
[3] Enable Med, Menlo Pk, CA USA
[4] Princess Alexandra Hosp, Brisbane, Qld, Australia
关键词
IMMUNITY;
D O I
10.1186/s12967-024-05035-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The spatial localisation of immune cells within tumours are key to understand the intercellular communications that can dictate clinical outcomes. Here, we demonstrate an analysis pipeline for highly multiplexed CODEX data to phenotype and profile spatial features and interactions in NSCLC patients that subsequently received PD1 axis immunotherapy. We found that regulatory T cells (Tregs) are enriched in non-responding patients and this was consistent with their localization within stromal and peripheral tumour-margins. Proximity-based interactions between Tregs and both monocytes (p = 0.009) and CD8+ T cells (p = 0.009) were more frequently found in non-responding patients, while macrophages were more frequently located in proximity to HLADR+ tumour cells (p = 0.01) within responding patients. Cellular neighbourhoods analysis indicated that both macrophages (p = 0.003) and effector CD4+ T cells (p = 0.01) in mixed tumour neighbourhoods, as well as CD8+ T cells (p = 0.03) in HLADR+ tumour neighbourhoods were associated with favorable clinical response. Evaluation of the inferred regulatory functions between immune cells relative to the tumour suggested that macrophages exhibit an immunosuppressive phenotype against both CD4+ and CD8+ T cells, and that this association scores more highly in ICI refractory patients. These spatial patterns are associated with overall survival in addition to ICI response and may thus indicate features for the functional understanding of the tumour microenvironment.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Advancing Understanding of Non-Small Cell Lung Cancer with Multiplexed Antibody-Based Spatial Imaging Technologies
    Gray, Simon
    Ottensmeier, Christian H.
    CANCERS, 2023, 15 (19)
  • [32] Unraveling functionally distinct metabolic programs to predict immunotherapy response in non-small cell lung cancer (NSCLC)
    Kulasinghe, A.
    Yan, R.
    Quinn, S.
    Falkenstein, B.
    Monkman, J.
    O'Byrne, K. J.
    Chennubhotla, S. C.
    Pullara, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S269 - S269
  • [33] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [34] Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
    Indini, Alice
    Rijavec, Erika
    Grossi, Francesco
    CANCERS, 2021, 13 (08)
  • [35] Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
    Oh, Michael S.
    Abascal, Jensen
    Rennels, Austin K.
    Salehi-Rad, Ramin
    Dubinett, Steven M.
    Liu, Bin
    CANCERS, 2025, 17 (06)
  • [36] Novel machine learning (ML) algorithm to predict immunotherapy response in small cell (SCLC) and non-small cell (NSCLC) lung cancer
    Sharma, L.
    Choi, S.
    Balaji, V.
    Joshi, A.
    Mporas, I.
    Shi, J.
    Zhao, Y.
    Tailor, V.
    Powell, G.
    Alrifai, D.
    Shah, R.
    Waters, J. S. C.
    Adeleke, O. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S261 - S261
  • [37] Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancer
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Matigian, Nicholas
    Cumberbatch, Marie
    Bhagat, Milan
    Ladwa, Rahul
    Mueller, Scott N.
    Adams, Mark N.
    O'Byrne, Ken
    Kulasinghe, Arutha
    IMMUNOLOGY, 2023, 169 (04) : 487 - 502
  • [38] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [39] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [40] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396